Literature DB >> 6681551

Spectrophotometric analysis of CSF after subarachnoid hemorrhage: limitations in the diagnosis of rebleeding.

M Vermeulen, J van Gijn, B G Blijenberg.   

Abstract

We studied the course of CSF xanthochromia after subarachnoid hemorrhage by serial spectrophotometric analysis of lumbar CSF in 15 patients without clinical or CT evidence of rebleeding. The xanthochromic index rose in some patients up to the seventeenth day, and the proportion of oxyhemoglobin or the absolute concentration of hemoglobin often fluctuated. Therefore, rebleeding can be demonstrated in lumbar CSF only by increased xanthochromia, if previous samples had shown a decrease. These criteria could be applied in only 6 of 17 consecutive patients with rebleeding as demonstrated by CT, and they were met in 5.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681551     DOI: 10.1212/wnl.33.1.112

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Investigation of the vasoconstrictor action of subarachnoid haemoglobin in the pig cerebral circulation in vivo.

Authors:  J V Byrne; T M Griffith; D H Edwards; T J Harrison; K R Johnston
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Hemoglobin quantitation in subarachnoid hemorrhage.

Authors:  H Mast; H Pöche; P Marx
Journal:  Klin Wochenschr       Date:  1987-06-01

Review 3.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

4.  Xanthochromia after subarachnoid haemorrhage needs no revisitation.

Authors:  M Vermeulen; D Hasan; B G Blijenberg; A Hijdra; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

Review 5.  Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.

Authors:  Merih I Baharoglu; Menno R Germans; Gabriel J E Rinkel; Ale Algra; Marinus Vermeulen; Jan van Gijn; Yvo B W E M Roos
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.